These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Highly purified lipopolysaccharides from Burkholderia cepacia complex clinical isolates induce inflammatory cytokine responses via TLR4-mediated MAPK signalling pathways and activation of NFkappaB. Bamford S; Ryley H; Jackson SK Cell Microbiol; 2007 Feb; 9(2):532-43. PubMed ID: 17002785 [TBL] [Abstract][Full Text] [Related]
4. The structure and proinflammatory activity of the lipopolysaccharide from Burkholderia multivorans and the differences between clonal strains colonizing pre and posttransplanted lungs. Ieranò T; Silipo A; Sturiale L; Garozzo D; Brookes H; Khan CM; Bryant C; Gould FK; Corris PA; Lanzetta R; Parrilli M; De Soyza A; Molinaro A Glycobiology; 2008 Nov; 18(11):871-81. PubMed ID: 18684854 [TBL] [Abstract][Full Text] [Related]
5. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species. Leitão JH; Sousa SA; Ferreira AS; Ramos CG; Silva IN; Moreira LM Appl Microbiol Biotechnol; 2010 Jun; 87(1):31-40. PubMed ID: 20390415 [TBL] [Abstract][Full Text] [Related]
6. The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315). Silipo A; Molinaro A; Ieranò T; De Soyza A; Sturiale L; Garozzo D; Aldridge C; Corris PA; Khan CM; Lanzetta R; Parrilli M Chemistry; 2007; 13(12):3501-11. PubMed ID: 17219455 [TBL] [Abstract][Full Text] [Related]
7. The O-chain structure from the LPS of the endophytic bacterium Burkholderia cepacia strain ASP B 2D. Leone S; Molinaro A; Gerber IB; Dubery IA; Lanzetta R; Parrilli M Carbohydr Res; 2006 Dec; 341(18):2954-8. PubMed ID: 17078936 [TBL] [Abstract][Full Text] [Related]
10. Structural study and conformational behavior of the two different lipopolysaccharide O-antigens produced by the cystic fibrosis pathogen Burkholderia multivorans. Ieranò T; Silipo A; Cescutti P; Leone MR; Rizzo R; Lanzetta R; Parrilli M; Molinaro A Chemistry; 2009 Jul; 15(29):7156-66. PubMed ID: 19533713 [TBL] [Abstract][Full Text] [Related]
11. Macrophage responses to CF pathogens: JNK MAP kinase signaling by Burkholderia cepacia complex lipopolysaccharide. McKeon S; McClean S; Callaghan M FEMS Immunol Med Microbiol; 2010 Oct; 60(1):36-43. PubMed ID: 20602636 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942 [TBL] [Abstract][Full Text] [Related]
13. Social interactions in the Burkholderia cepacia complex: biofilms and quorum sensing. Coenye T Future Microbiol; 2010 Jul; 5(7):1087-99. PubMed ID: 20632807 [TBL] [Abstract][Full Text] [Related]
14. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. De Soyza A; Ellis CD; Khan CM; Corris PA; Demarco de Hormaeche R Am J Respir Crit Care Med; 2004 Jul; 170(1):70-7. PubMed ID: 15044201 [TBL] [Abstract][Full Text] [Related]
15. Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice. Sousa SA; Ulrich M; Bragonzi A; Burke M; Worlitzsch D; Leitão JH; Meisner C; Eberl L; Sá-Correia I; Döring G Cell Microbiol; 2007 Dec; 9(12):2817-25. PubMed ID: 17627623 [TBL] [Abstract][Full Text] [Related]
16. Structural elucidation of the novel core oligosaccharide from LPS of Burkholderia cepacia serogroup O4. Masoud H; Perry MB; Brisson JR; Uhrin D; Li J; Richards JC Glycobiology; 2009 May; 19(5):462-71. PubMed ID: 19141607 [TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion. Lynch JP Semin Respir Crit Care Med; 2009 Oct; 30(5):596-610. PubMed ID: 19760547 [TBL] [Abstract][Full Text] [Related]
18. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans. Caraher E; Duff C; Mullen T; Mc Keon S; Murphy P; Callaghan M; McClean S J Cyst Fibros; 2007 Jan; 6(1):49-56. PubMed ID: 16781896 [TBL] [Abstract][Full Text] [Related]
19. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms. Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284 [TBL] [Abstract][Full Text] [Related]
20. Cloaking antibodies are prevalent in Pham A; Tan KKY; Ledger EL; Smith DJ; Reid DW; Burr L; Chambers DC; Wells TJ Front Cell Infect Microbiol; 2024; 14():1426773. PubMed ID: 39193503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]